يعرض 121 - 140 نتائج من 46,495 نتيجة بحث عن '(( 5 we decrease ) OR ((( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 non decrease ))))', وقت الاستعلام: 1.11s تنقيح النتائج
  1. 121

    Data used to generate Table 5. حسب Pattamaporn Kittayapong (289542)

    منشور في 2025
    "…The eggs of both wild-type and <i>Wolbachia</i> trans-infected lines were irradiated using X-ray at the doses of 1, 3, 5 and 7 Gy. Development of immature stages was observed. …"
  2. 122
  3. 123
  4. 124
  5. 125
  6. 126
  7. 127
  8. 128

    Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lun... حسب Feiyun Chang (12243382)

    منشور في 2022
    "…The regulation mechanism of circ_0017639 was demonstrated by a dual-luciferase reporter assay. We observed higher levels of circ_0017639 in DDP-resistant NSCLC samples and cells. …"
  9. 129

    DataSheet5_First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis.docx حسب Qiao Liu (346535)

    منشور في 2021
    "…</p><p>Conclusion: For advanced NSCLC patients with PD-L1 of at least 50%, cemiplimab was a cost-effective option compared with pembrolizumab and a dominant alternative against atezolizumab. …"
  10. 130
  11. 131

    Fig 5 - حسب Debarpan Dhar (724473)

    منشور في 2024
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136

    Table_1_Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2.docx حسب Yun Ji (464484)

    منشور في 2022
    "…However, the continuous virus evolution requires diverse mAb options to combat variants. Here we describe two fully human mAbs, amubarvimab (BRII-196) and romlusevimab (BRII-198) that bind to non-competing epitopes on the receptor binding domain (RBD) of spike protein and effectively neutralize SARS-CoV-2 variants. …"
  17. 137
  18. 138
  19. 139
  20. 140